| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 143, 1423-1435, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Lundstrom, RA Orlando, MS Saedi, L Woodward, H Kurihara and MG Farquhar
Division of Cellular and Molecular Medicine, University of California, San Diego, La Jolla 92093-0651.
Heymann nephritis in the rat is the most widely used model of human membranous glomerulonephritis. Glycoprotein (gp)330, a large (M(r) > 550,000) membrane-associated glycoprotein, has been identified as the main antigen in this autoimmune disease. Studies of gp330 and receptor- associated protein (RAP), its 44-kd subunit, have been restricted largely to rat kidney, as no stable cultured cell line has been available that expresses gp330. We have recently identified a rat yolk sac carcinoma cell line (L2) that expresses both gp330 and RAP. In this report, we have carried out detailed morphological, immunocytochemical, and biochemical studies characterizing the biosynthesis and localization of gp330 and RAP in the L2 rat yolk sac cell line. At the electron microscope level, the L2 cells are seen to be attached by cell junctions, and their predominant morphological features include extensive networks of rough endoplasmic reticulum (ER) and numerous clathrin-coated pits found on the cell membrane. By immunocytochemistry, gp330 was localized primarily to clathrin-coated pits at the cell surface, whereas RAP was localized predominantly to the lumen of the rough ER. Pulse-chase experiments indicated that gp330 spends a prolonged time maturing in the ER of L2 cells, as transport of gp330 to the Golgi complex (based on acquisition of endoglycosidase H resistance) is slow (t1/2 = 90 to 120 minutes). Gp330 reached the L2 cell surface beginning at 2 hours after synthesis, where it could be detected by cell surface immunoprecipitation. RAP was found to be an N- linked glycoprotein, and it remained endoglycosidase H-sensitive up to 4 hours after synthesis. Co-precipitation and co-sedimentation experiments demonstrated that gp330 and RAP form a large heterodimer (M(r) approximately 669,000) immediately after biosynthesis and are further assembled into a large hetero-oligomer in the ER. These findings demonstrate that the localization and the kinetics of assembly of gp330 and RAP into the Heymann nephritis antigenic complex are similar in both L2 cells and rat kidney. They also provide new information on the intracellular processing of these two molecules and their delivery to the cell surface. Thus, the L2 cell system should facilitate further characterization of the functions and interactions of gp330 and RAP, which may shed light on the cellular and molecular mechanisms of Heymann nephritis.
This article has been cited by other articles:
![]() |
L. A Woollett Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1155 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hama, A. Saito, T. Takeda, A. Tanuma, Y. Xie, K. Sato, J. J. Kazama, and F. Gejyo Evidence Indicating that Renal Tubular Metabolism of Leptin Is Mediated by Megalin But Not by the Leptin Receptors Endocrinology, August 1, 2004; 145(8): 3935 - 3940. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagai, T. Meerloo, T. Takeda, and M. G. Farquhar The Adaptor Protein ARH Escorts Megalin to and through Endosomes Mol. Biol. Cell, December 1, 2003; 14(12): 4984 - 4996. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saito, J. J. Kazama, N. Iino, K. Cho, N. Sato, H. Yamazaki, Y. Oyama, T. Takeda, R. A. Orlando, F. Shimizu, et al. Bioengineered Implantation of Megalin-Expressing Cells: A Potential Intracorporeal Therapeutic Model for Uremic Toxin Protein Clearance in Renal Failure J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2025 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saito, R. Nagai, A. Tanuma, H. Hama, K. Cho, T. Takeda, Y. Yoshida, T. Toda, F. Shimizu, S. Horiuchi, et al. Role of Megalin in Endocytosis of Advanced Glycation End Products: Implications for a Novel Protein Binding to Both Megalin and Advanced Glycation End Products J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1123 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Wilsie and R. A. Orlando The Low Density Lipoprotein Receptor-related Protein Complexes with Cell Surface Heparan Sulfate Proteoglycans to Regulate Proteoglycan-mediated Lipoprotein Catabolism J. Biol. Chem., April 25, 2003; 278(18): 15758 - 15764. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lou, T. McQuistan, R. A. Orlando, and M. G. Farquhar GAIP, GIPC and G{alpha}i3 are Concentrated in Endocytic Compartments of Proximal Tubule Cells: Putative Role in Regulating Megalin's Function J. Am. Soc. Nephrol., April 1, 2002; 13(4): 918 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. RADER, R. A. ORLANDO, X. LOU, and M. G. FARQUHAR Characterization of ANKRA, a Novel Ankyrin Repeat Protein that Interacts with the Cytoplasmic Domain of Megalin J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2167 - 2178. [Abstract] [Full Text] |
||||
![]() |
J. A. McConihay, A. M. Honkomp, N. A. Granholm, and L. A. Woollett Maternal high density lipoproteins affect fetal mass and extra-embryonic fetal tissue sterol metabolism in the mouse J. Lipid Res., March 1, 2000; 41(3): 424 - 432. [Abstract] [Full Text] |
||||
![]() |
K. L. Wyne and L. A. Woollett Transport of maternal LDL and HDL to the fetal membranes and placenta of the Golden Syrian hamster is mediated by receptor-dependent and receptor-independent processes J. Lipid Res., March 1, 1998; 39(3): 518 - 530. [Abstract] [Full Text] |
||||
![]() |
M. Jareb and G. Banker Inhibition of Axonal Growth by Brefeldin A in Hippocampal Neurons in Culture J. Neurosci., December 1, 1997; 17(23): 8955 - 8963. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Czekay, R. Orlando, L Woodward, E. Adamson, and M. Farquhar The expression of megalin (gp330) and LRP diverges during F9 cell differentiation J. Cell Sci., January 4, 1995; 108(4): 1433 - 1441. [Abstract] [PDF] |
||||
![]() |
R. A. Girton, D. P. Sundin, and M. E. Rosenberg Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity Am J Physiol Renal Physiol, April 1, 2002; 282(4): F703 - F709. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |